Summary
Chapters
Video Info
In episode 2 of The Parkinson's Drug Trial: A Miracle Cure?, Kate Fleetwood continues the journey of six volunteers as they participate in a clinical trial for glial-cell derived neurotrophic factor (GDNF), as a treatment for Parkinson's disease.
-
Chapter 1: Introductory Sequences for The Parkinson's Drug Trial: A Miracle Cure? Episode 2
icon angle down -
Chapter 2: The Second Half of the Phase II GDNF Clinical Begins and all Participants Receive GDNF
icon angle down -
Chapter 3: Participants Share Their Experiences During the Second Half of the Phase II GDNF Clinical Trial
icon angle down -
Chapter 4: A Set Back and an Upgrade for Tom Isaacs During the Phase II GDNF Clinical Trial
icon angle down -
Chapter 5: Participants Share Their Progress as the Phase II GDNF Clinical Trial Winds Down
icon angle down -
Chapter 6: The Primary Results of the Phase II GDNF Clinical Trial Are Presented
icon angle down -
Chapter 7: The Secondary Findings of the Phase II GDNF Clinical Trial Show Promise
icon angle down -
Chapter 8: The Phase II GDNF Clinical Trial Officially Ends and GDNF Loses a Strong Advocate
icon angle down -
Chapter 9: Pfizer Shuts Down Its Neuroscience Research Division and the Search for New Funding Begins
icon angle down -
Chapter 10: Closing Comments and Credits for The Parkinson's Drug Trial: A Miracle Cure? Episode 2
icon angle down